SE7416195L - Forfarande for framstellning av cefalosporiner. - Google Patents

Forfarande for framstellning av cefalosporiner.

Info

Publication number
SE7416195L
SE7416195L SE7416195A SE7416195A SE7416195L SE 7416195 L SE7416195 L SE 7416195L SE 7416195 A SE7416195 A SE 7416195A SE 7416195 A SE7416195 A SE 7416195A SE 7416195 L SE7416195 L SE 7416195L
Authority
SE
Sweden
Prior art keywords
cephalosporins
procedure
preparation
Prior art date
Application number
SE7416195A
Other languages
English (en)
Swedish (sv)
Inventor
J Bradshaw
M C Cook
G I Gregory
J D Cocker
D R Sutherland
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB59517/73A external-priority patent/GB1496757A/en
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of SE7416195L publication Critical patent/SE7416195L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE7416195A 1973-12-21 1974-12-20 Forfarande for framstellning av cefalosporiner. SE7416195L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB59517/73A GB1496757A (en) 1973-12-21 1973-12-21 Cephalosporin derivatives
GB4300574 1974-10-03

Publications (1)

Publication Number Publication Date
SE7416195L true SE7416195L (sv) 1975-09-22

Family

ID=26265028

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7416195A SE7416195L (sv) 1973-12-21 1974-12-20 Forfarande for framstellning av cefalosporiner.

Country Status (15)

Country Link
JP (1) JPS5844675B2 (xx)
AT (1) AT344888B (xx)
CH (1) CH617703A5 (xx)
DE (1) DE2460537A1 (xx)
DK (1) DK674674A (xx)
ES (2) ES433226A1 (xx)
FI (1) FI65258C (xx)
FR (1) FR2255076B1 (xx)
HU (1) HU172234B (xx)
IE (1) IE42144B1 (xx)
IL (1) IL46302A (xx)
LU (1) LU71550A1 (xx)
NL (1) NL7416665A (xx)
NO (1) NO744621L (xx)
SE (1) SE7416195L (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4095021A (en) 1973-12-21 1978-06-13 Glaxo Laboratories Limited 3-Carbamoyloxymethyl or N-methyl-carbamoyloxymethyl-7-[2-carboxymethoxyimino-2-(fur-2-yl or thien-2-yl)acetamido]ceph-3-em-4-carboxylic acids and derivatives thereof
US4144392A (en) 1973-12-21 1979-03-13 Glaxo Laboratories Limited Cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyimino-arylacetamido group and at position-3 the residue of a sulphur nucleophile
GB1555471A (en) * 1975-06-19 1979-11-14 Glaxo Lab Ltd 7 carbamoylalkoxyimino acetamido 3 em 4 carboxylic acidsand derivatives thereof
CA1093549A (en) * 1976-02-16 1981-01-13 Michael Gregson Cephalosporin antibiotics
US4165430A (en) 1976-03-19 1979-08-21 Glaxo Laboratories Limited Cephalosporins having a 7-carboxy substituted α-etherified oximinoarylacetamido) group
US4304770A (en) 1976-04-12 1981-12-08 Fujisawa Pharmaceutical Co., Ltd. Syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for the preparation thereof
US4066762A (en) * 1976-07-12 1978-01-03 Smithkline Corporation Derivatives of 7-(2-substituted-2-hydroxyiminoacetamido)-3-(1-substituted tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid
US4278670A (en) * 1976-07-12 1981-07-14 Smithkline Corporation 7-Alpha-oxyiminoacylcephalosporins
GB1591439A (en) 1976-10-01 1981-06-24 Glaxo Operations Ltd 7-syn (oxyimino -acylamido) cephalosporins
GB1596278A (en) 1976-11-30 1981-08-26 Glaxo Operations Ltd 7-(-oxyimino-acetamino)cephalosporin derivatives
PH17188A (en) 1977-03-14 1984-06-14 Fujisawa Pharmaceutical Co New cephem and cepham compounds and their pharmaceutical compositions and method of use
SE439312B (sv) * 1977-03-25 1985-06-10 Roussel Uclaf Sett att framstella nya oximderivat av 3-acetoximetyl-7-aminotiazolylacetamido cefalosporansyra
ES485441A1 (es) * 1978-10-27 1980-07-01 Glaxo Group Ltd Un procedimiento para la preparacion de antibioticos de ce- falosporina
FR2457296A1 (fr) * 1979-05-23 1980-12-19 Rhone Poulenc Ind Nouveaux derives de vinyl-3 cephalosporines et leur preparation
FR2552432B2 (fr) * 1983-09-27 1985-10-25 Roussel Uclaf Nouvelles oximes derivees de l'acide 2-amino thiazol- 4-yl acetique, procede de preparation
US20040166434A1 (en) 2003-02-21 2004-08-26 Dammel Ralph R. Photoresist composition for deep ultraviolet lithography

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds
GB1348984A (en) * 1970-06-16 1974-03-27 Merck & Co Inc Antibiotics and processes for their production
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds

Also Published As

Publication number Publication date
CH617703A5 (en) 1980-06-13
JPS50105689A (xx) 1975-08-20
FR2255076B1 (xx) 1978-11-10
NL7416665A (nl) 1975-06-24
DE2460537A1 (de) 1975-07-03
FI371374A (xx) 1975-06-22
ATA1020174A (de) 1977-12-15
NO744621L (xx) 1975-07-21
ES433226A1 (es) 1977-07-01
DK674674A (xx) 1975-09-08
HU172234B (hu) 1978-07-28
FR2255076A1 (xx) 1975-07-18
FI65258C (fi) 1984-04-10
IE42144L (en) 1975-06-21
FI65258B (fi) 1983-12-30
LU71550A1 (xx) 1976-04-13
ES451604A1 (es) 1977-12-16
IE42144B1 (en) 1980-06-18
IL46302A (en) 1978-09-29
AT344888B (de) 1978-08-10
IL46302A0 (en) 1975-03-13
AU7673574A (en) 1976-06-24
DE2460537C2 (xx) 1987-01-22
JPS5844675B2 (ja) 1983-10-04

Similar Documents

Publication Publication Date Title
SE423631B (sv) Forfarande for framstellning av oxaalhyl-dialkylxantiner
NO145273C (no) N-formyl-alfa-l-aspartyl-l-fenylalanin for anvendelse til fremstilling av alfa-l-aspartyl-l-fenylalaninalkylestere
SE7710599L (sv) Forfarande for framstellning av bensisoxazoler
SE7416195L (sv) Forfarande for framstellning av cefalosporiner.
SE411212B (sv) Forfarande for framstellning av 3-halogen-cefalosporiner
SE420604B (sv) Forfarande for framstellning av oxazolderivat
NO147916C (no) Fremgangsmaate for fremstilling av 3-metylen-cefalosporin-forbindelser.
RO70474A (ro) PROCEDEU PENTRU PREPARAREA PARAXILENULёI
NO143531C (no) Fremgangsmaate for fremstilling av acylerte benzoksazolinon-derivater.
NO146596C (no) Fremgangsmaate for fremstilling av 6-deoksytetracykliner
SE7712151L (sv) Forfarande for framstellning av linkomycinderivat
SE417601B (sv) Forfarande for framstellning av amidinokarbamider
NO790627L (no) Fremgangsmaate for fremstilling av hydroksyalkylxantiner
NO153806C (no) Fremgangsmaate for fremstilling av 6-deoksytetracyklin.
NO741486L (no) Fremgangsmåte for fremstilling av xylitol.
SE417319B (sv) Analogiforfarande for framstellning av ergopeptiner
TR17584A (tr) Herbisid triazinlerinin hazirlanmasina mahsus usul
SE409716B (sv) Analogiforfarande for framstellning av 11beta-alkyl-deltaŸ4-estrener
SE431451B (sv) Forfarande for framstellning av 2,3-dihydroxipropoxikinoliner eller -isokinoliner
SE411211B (sv) Forfarande for framstellning av 3-halogencefalosporiner
SE409994B (sv) Forfarande for framstellning av amidinokarbamider
SE7613500L (sv) Forfarande for framstellning av cefemderivat
SE401835B (sv) Forfarande for framstellning av 17beta-hydroxi-16,16-dimetylest-4-en-3-on
NO141851C (no) Fremgangsmaate for fremstilling av metyl-3-(2-kinoksalinylmetylen)-karbazat-n1.n4-dioksyd.
SE401506B (sv) Forfarande for framstellning av bifenylyletrar